🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase IIIb, randomized, open-label, parallel group, active control, mu...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11-21
Trial ID
NCT02229227
Treatments Being Tested
This study is designed to examine the efficacy and safety of 2 dose levels ...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-02
Trial ID
NCT01733758
Treatments Being Tested
Albiglutide is an analogue of glucagon-like peptide-1 (GLP-1), used to trea...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-07-01
Trial ID
NCT02465515
Treatments Being Tested
This study is designed to examine the long term safety and efficacy of week...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-02-23
Trial ID
NCT01777282
Treatments Being Tested
This is a Phase II, randomized, double-blind, parallel group, placebo contr...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-10-10
Trial ID
NCT02284009
Treatments Being Tested
Albiglutide has been developed for the treatment of type 2 diabetes mellitu...
Status
Terminated
Location
GSK Investigational Site
Start Date
2016-10-07
Trial ID
NCT02750930
Treatments Being Tested
This Phase IIIb, randomized, double-blind, parallel-group, placebo-controll...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-08
Trial ID
NCT02229240
Treatments Being Tested
The primary objective of this study is to compare the effect of albiglutide...
Status
Terminated
Location
GSK Investigational Site
Start Date
2016-09-26
Trial ID
NCT02793154
Treatments Being Tested